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Summary
Background Human papillomaviruses (HPVs) are sexually transmitted human carcin-
ogens that may play a role in the oncogenesis of penile cancer.
Objectives To investigate the role of HPV infection and expression of the tumour
suppressor protein p16INK4A in the pathogenesis of penile cancer.
Methods By means of polymerase chain reaction amplification and reverse hybrid-
ization line probe assay to detect HPV infection, and immunohistochemical stain-
ing for p16INK4A and Ki67, we analysed 26 penile squamous cell carcinomas
(SCCs) and 20 independent penile lichen sclerosus (LS) lesions from 46 patients.
Results HPV DNA was found in 54% of penile SCCs and 33% of penile LS cases in
single and multiple infections. High-risk HPV 16 was the predominant HPV type
detected. No relationship between Ki67 expression and HPV infection was
observed. Strong immunostaining for p16INK4A correlated with HPV 16 ⁄18 infec-
tion in both penile LS and penile SCC. In our penile SCC series the cancer mar-
gins were also associated with penile LS in 13 of 26 lesions, and HPV was
detected in seven of the 13 SCC cases associated with LS and in six of the 11
SCC lesions not involving LS.
Conclusions Our study shows a high prevalence of HPV 16 and p16INK4A expression
in penile lesions, consistent with an active role for HPV in interfering with the
retinoblastoma pathway. High-risk HPV infection could be involved in the
tumorigenic process in 50% of penile cancers, and the use of prophylactic HPV
vaccines has the potential to prevent these cancers.
Penile cancer accounts for 0Æ3–0Æ6% of all cancers in men in
the Western world and this incidence is much higher in some
African, Asian and South American countries.1,2 Early diagno-
sis of penile cancer is both lifesaving and essential for cosmet-
ically acceptable treatment. The most common histological
type of penile cancer is squamous cell carcinoma (SCC),
accounting for 95% of cases. Its aetiology is unknown, but
risk factors include age and lack of circumcision.1,2 Penile
lichen sclerosus (LS) or balanitis xerotica obliterans is a
chronic inflammatory disorder of unknown cause that may be
a predisposing factor to the development of penile SCC, as
3–6% of patients with penile LS are reported to develop penile
carcinoma3,4 and 28–50% of penile SCC cases have associated
LS.5–7 Vulval LS is also considered one of two pathways for
the development of vulval cancer, the other being via human
papillomavirus (HPV) infection.8
Persistent infection with sexually transmitted high-risk HPV
is the main cause of cervical cancer,9,10 and HPV infection
may also play a role in penile carcinogenesis.11 A common
aetiology for penile and cervical cancer is suggested by the
geographical correlation between the incidence of penile and
cervical cancers worldwide.12 Male circumcision, which is
associated with a reduced risk of penile cancer,1,2 has also
been associated with decreased penile HPV infection and, in
the case of men with a history of multiple sexual partners, a
reduced risk of cervical cancer in their current female part-
ners.13 The prevalence of HPV penile infections in healthy
men is 3–9% in Western Europe which has a low incidence
of penile cancer and 39% in Brazil where penile cancer rates
are higher.14,15 However, unlike cervical cancer where it is
considered that all cancers are HPV related and HPV infection
can be detected in almost all cases,9 the infection rates of HPV
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in penile cancer range from 20% to 80%, depending on
detection method and geographical location.1,2
HPV contributes to tumorigenesis predominantly through
the action of the viral oncoproteins (E6 and E7). The inter-
action of E7 with the retinoblastoma (Rb) tumour suppressor
leads to Rb degradation, E2F activation and overexpression of
the cyclin-dependent kinase inhibitor p16INK4A.16,17 The
objective of this study was to examine the prevalence of HPV
DNA in penile LS and SCC and to investigate whether penile
HPV infection is associated with p16INK4A expression in both
types of lesion.
Materials and methods
Patient samples, DNA preparation and human
papillomavirus genotyping
Archival paraffin wax-embedded tissue sections from 26 penile
SCCs, 20 penile LS cases not associated with SCC and 26 cervi-
cal cancers (Barts and The London NHS Trust) were obtained
and reviewed by a pathologist (S.B.), with ethical approval
from the East London and City Health Authority Research Eth-
ics Committee (P-02-84 and P-03-302). DNA was extracted
from paraffin wax-embedded sections using the QIAamp DNA
Mini kit (Cat. No. 51304; Qiagen, Crawley, U.K.). b-Globin
polymerase chain reaction (PCR) was performed using primers
B1 and B19 to confirm the adequacy of the extracted DNA.
Validated samples were tested for the presence of HPV DNA
by a broad-spectrum HPV PCR method using SPF10 primers
which amplify a 65-bp fragment of the L1 open reading
frame.18 HPV genotypes were identified by the INNO-LiPA
line probe assay (Innogenetics NV, Ghent, Belgium).19,20
Immunohistochemistry
Antigen retrieval using citrate buffer was performed on
dewaxed sections prior to blocking with swine serum. Primary
antibodies to Ki67 (MIB-1; Dako Cytomation, Glostrup, Den-
mark; M 7240, dilution 1 : 50) and p16INK4A (Ab-7; Neomar-
kers, Fremont, CA, U.S.A.; MS-1064-P0, dilution 1 : 100)
were applied for 1 h and detected using an Envision Kit (Dako
Cytomation; K4006). p16INK4A staining was assessed by grad-
ing the intensity (0, negative; 1, low intensity; 2, mid range;
3, high intensity) and percentage of positively stained cells
(1, low percentage coverage, 0–33%; 2, mid percentage
coverage, 34–67%; 3, high percentage coverage, 68–100%).
The combined score total was calculated by adding together
the intensity and percentage coverage scores. Ki67 staining
was assessed by the percentage of positively stained cells only.
Statistical analysis was performed using Fisher’s exact test and
SPSS software (SPSS, Chicago, IL, U.S.A.). P < 0Æ05 was con-
sidered significant.
Results
An analysis of tissue samples from 26 penile carcinomas, 20
penile LS cases not associated with SCC and 26 cervical cancers
was performed to determine HPV prevalence and genotype
(Table 1). Two cases of penile LS were excluded from study
due to negative b-globin results. High-risk HPV infection was
present in 14 of 26 (54%) penile cancers, six of 18 (33%)
penile LS cases and 24 of 26 (92%) cervical cancers (Table 1).
HPV infections were significantly lower in penile LS and SCC
than in cervical carcinoma (P < 0Æ05). There was no signifi-
cant difference in the number of multiple HPV infections
between penile LS and SCC. For both penile LS and SCC, HPV-
positive cases consisted of 50% single infections and 50%
multiple infections. Similar frequencies were observed in our
cervical cancer series (58% single infections and 42% multiple
infections). High-risk HPV genotypes were detected in all
HPV-positive penile lesions and cervical cancers. Only high-
risk HPV 16 and 18 were found as single infections in penile
cancer. HPV 16, which is strongly associated with malignant
mucosal lesions, was the most commonly occurring HPV type
in single and multiple HPV infections in penile LS, penile SCC
and cervical cancers. HPV 16 was detected in all six HPV-
positive penile LS cases, 11 of 14 (79%) HPV-positive penile
SCCs and 20 of 22 (91%) HPV-positive cervical cancers.
High-risk HPV 18, 39, 45, 52 or 68 infections were detected
in the three HPV-positive penile cancers lacking HPV 16 and
in some of the multiple infections with HPV 16 and HPV 6,
33, 40, 42, 51 or 56.
We examined the expression of proliferation marker Ki67
and p16INK4A in penile LS and SCC by immunohistochemistry.
Table 1 Human papillomavirus (HPV) DNA polymerase chain reaction and genotype distribution in penile lichen sclerosus (LS), penile squamous
cell carcinoma (SCC) and cervical carcinoma
HPV genotype distribution
Diagnosis n HPV 16 18 53 16 16 16 16 16 40a 16 16 16 18 11a 16 39 16 6a
DNA 18 33 56 52 66 52 52 56 33 45 16 45 68 18 16
Positive 68 18 56 68 56 56 52 33 42a
51 44a
Penile LS 18 6 (33%) 3 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 1 0
Penile SCC 26 14 (54%) 6 1 0 0 0 3 0 0 1 1 0 0 0 0 0 1 0 1
Cervical carcinoma 26 24 (92%) 13 0 1 1 0 2 1 1 0 0 1 1 1 1 1 0 0 0
aLow risk or unclassified HPV genotype.
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Staining for Ki67 and p16INK4A was observed in both penile
LS and SCC (Fig. 1). No relationship between Ki67 expression
and p16INK4A or HPV infection was observed (Table 2). In
contrast, strong immunostaining for p16INK4A was found
in approximately 50% of the penile lesions and this was
associated with HPV 16 ⁄18 infection in both penile SCC and
penile LS (P < 0Æ05) (Table 2).
In our penile SCC series the cancer margins were also asso-
ciated with penile LS in 13 of 24 cases (54%), with two cases
uncharacterized due to insufficient noncancerous material.
HPV was detected in seven of the 13 (54%) SCC cases associ-
ated with LS and in six of the 11 (55%) SCC cases not involv-
ing LS.
Discussion
We have established the prevalence of HPV DNA in penile LS
and SCC and found an association with high-risk HPV 16 ⁄18
and p16INK4A expression. Penile LS has been proposed to be a
premalignant lesion predisposing for penile cancer develop-
ment.5,6 However, there is only one report of the incidence
of HPV infection in penile LS. Our detection of high-risk HPV
16 in 33% of our penile LS cases is higher than in a recent
Italian study, which found it in 17% of penile LS cases. We
detected HPV infections in 54% of our penile cancer cases,
which is consistent with recent reports that have found HPV
in 30% of Dutch21,22 and 77% of Spanish23 penile carcin-
omas. HPV infections were more common in our penile can-
cers (54%) than in LS cases (33%). We found concurrent
infection with more than one HPV type in 50% of infected
(a) (b) (c)
(d) (e) (f)
Fig 1. Representative examples of p16INK4A and Ki67 immunohistochemistry showing (a) high levels of p16INK4A-immunoreactive penile
squamous cell carcinoma (SSC) [note positive nuclear and cytoplasmic staining (brown)]; (b) low levels of p16INK4A-immunoreactive penile SSC;
(c) high levels of p16INK4A-immunoreactive penile lichen sclerosus (LS); (d) high levels of Ki67-immunoreactive penile SSC [note positive nuclear
staining (brown)]; (e) low levels of Ki67-immunoreactive penile SSC; and (f) high levels of Ki67-immunoreactive penile LS.
Table 2 p16INK4A and Ki67 expression in penile lichen sclerosus (LS),
penile squamous cell carcinoma (SCC) and cervical carcinoma
p16INK4A Ki67
Diagnosis HPV PCR 0–3 4–6 0–1 2–3
Penile LS HPV 16 ⁄18+ 0 6* 0 6
HPV) 8 4 0 12
Total 8
(45%)
10
(55%)
0
(0%)
18
(100%)
Penile SCC HPV 16 ⁄18+ 4 8* 4 8
HPV other+ 2 0 0 2
HPV) 9 3 3 9
Total 15
(54%)
11
(46%)
7
(27%)
19
(73%)
Cervical
carcinoma
HPV 16 ⁄18+ 3 20 11 12
HPV other+ 0 1 0 1
HPV) 0 2 0 2
Total 3
(12%)
23
(88%)
11
(42%)
15
(58%)
PCR, polymerase chain reaction. *In penile LS and SCC high
levels of expression of p16INK4A are significantly associated with
high-risk human papillomavirus (HPV) 16 ⁄18 infection
(P < 0Æ05).
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subjects in both penile LS and SCC. Multiple infections have
not previously been reported in penile LS15 but have been
observed in up to 20% of penile SCCs.22,24,25 Multiple HPV
infections have also been reported in patients with cervical
abnormalities or cancers26 and in some studies but not others
this has been associated with a higher risk of cervical intraepi-
thelial neoplasia.27,28 However, in HPV co-infections one HPV
type may proliferate causing pathogenesis while the others are
latent bystanders.26
High-risk HPV 16 was the most prevalent HPV genotype
detected in each of our penile series, infecting 100% of HPV-
positive penile LS and 79% of HPV-positive penile SCC cases.
HPV 16 and HPV 18 were the only HPV genotypes occurring
as single infections, suggesting that these genotypes are more
likely to contribute to the carcinogenic process. HPV 16 and
18 are the predominant high-risk HPV genotypes associated
with cervical cancer.12,26 HPV 16 was the most frequently
detected genotype in Italian patients with LS, found in six of
eight HPV-positive cases.15 Our study of HPV infection in
penile carcinoma is in accordance with most other investiga-
tions which find HPV 16 as the commonest genotype detected
in Europe,21–23 although in Argentina and Thailand HPV 18
can predominate.29,30
p16INK4A expression in penile LS has not previously been
reported, and we are aware of only one paper reporting
p16INK4A expression in penile cancer.21 The expression of
p16INK4A and the proliferation marker Ki67 has been described
in gynaecological pathology.16,17,31 We found that expression
of Ki67 was high in all cases of penile LS and 73% of penile
SCCs and did not correlate with HPV infection. In contrast,
strong expression of p16INK4A which occurred in 55% of
penile LS and 46% of penile SCC cases was significantly associ-
ated with HPV 16 ⁄18 infection. This association is in agree-
ment with Ferreux et al. who reported that increased p16INK4A
expression correlated with HPV detection and occurred in
29% of penile SCCs,21 although we observed higher levels of
HPV infection and p16INK4A expression in our series. In the
two cervical cancer, three penile SCC and four penile LS cases
where p16INK4A was strongly expressed and no HPV was
detected, the levels of HPV may be too low for detection or
HPV types may be present that are not amplified by the SPF10
system.18 In the absence of HPV infection p16INK4A expression
is frequently inhibited by methylation or mutation in penile
SCC21,32 and nonpenile cutaneous SCC.33 Inactivation of
p16INK4A indirectly by HPV or by methylation and muta-
tion therefore appears to be an important step in penile tumori-
genesis.
Our observation that penile SCC was associated with LS in
54% of our cancer cases is consistent with LS being a predis-
posing factor to the development of penile and vulval SCC.5–8
However, vulval SCC linked to LS has not been associated with
HPV infection and conflicting results have been reported for
the involvement of HPV in the development of SCC in patients
with penile LS. Perceau et al. found HPV in five of nine SCCs
without LS association and only one of eight SCCs with LS
association,34 while in contrast Nasca et al. reported HPV 16
infection in two of three penile SCCs that developed in a series
of 86 patients with LS.3 Our results show high-risk HPV 16
infections to occur in patients with LS. We also found HPV 16
infections at a similar frequency (50%) in penile SCC with LS
association and in penile SCC without LS association. Persistent
HPV infection could be involved in the tumorigenic process in
approximately 50% of penile cancers, as unresolved HPV infec-
tion is a risk factor for cervical cancer.20
The importance of HPV status in penile cancer progression
and patient survival is controversial. High-risk HPV has tradi-
tionally been associated with aggressive variants,35 but recent
series examining the relationship of HPV infection with prog-
nosis have revealed either no correlation with lymph node
metastasis and survival25 or a favourable survival outcome.22
In summary, high-risk HPV infection occurs in both penile
LS and SCC and is associated with p16INK4A expression.
Expression of p16INK4A may therefore be of value as a surro-
gate marker confirming the diagnosis of HPV-infected prema-
lignant and malignant penile lesions. HPV 16 predominates in
penile LS and SCC and it is likely to be an aetiological agent
in the development of a significant proportion of penile can-
cers. These results are important as prophylactic HPV vaccines
being developed for prevention of cervical cancer in women
could also prevent penile cancers in men.
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